Inverness Counsel LLC NY Reduces Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Inverness Counsel LLC NY lessened its stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 1.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 136,009 shares of the healthcare conglomerate’s stock after selling 1,860 shares during the period. UnitedHealth Group makes up about 3.1% of Inverness Counsel LLC NY’s holdings, making the stock its 9th biggest holding. Inverness Counsel LLC NY’s holdings in UnitedHealth Group were worth $69,361,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Outfitter Financial LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at $25,000. Advocacy Wealth Management Services LLC grew its stake in shares of UnitedHealth Group by 75.8% during the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. boosted its position in UnitedHealth Group by 100.0% in the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 30 shares during the last quarter. Tortoise Investment Management LLC boosted its position in UnitedHealth Group by 54.8% in the 4th quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 23 shares in the last quarter. Finally, Leverty Financial Group LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $34,000. 87.48% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction that occurred on Thursday, May 19th. The shares were sold at an average price of $478.96, for a total transaction of $1,197,400.00. Following the completion of the transaction, the director now owns 1,215,000 shares in the company, valued at approximately $581,936,400. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $478.96, for a total value of $1,197,400.00. Following the transaction, the director now directly owns 1,215,000 shares of the company’s stock, valued at approximately $581,936,400. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Andrew Witty sold 11,376 shares of the company’s stock in a transaction on Monday, July 18th. The stock was sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the transaction, the chief executive officer now directly owns 76,559 shares in the company, valued at $40,415,496.10. The disclosure for this sale can be found here. Insiders have sold 17,649 shares of company stock valued at $9,071,142 over the last ninety days. Company insiders own 0.40% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on UNH. Morgan Stanley raised their target price on UnitedHealth Group from $570.00 to $587.00 in a report on Monday, July 18th. Raymond James upped their target price on UnitedHealth Group from $540.00 to $620.00 and gave the company a “strong-buy” rating in a research note on Tuesday, April 19th. Royal Bank of Canada set a $563.00 target price on UnitedHealth Group and gave the stock an “outperform” rating in a research report on Monday, April 18th. BMO Capital Markets raised their price objective on UnitedHealth Group from $600.00 to $610.00 in a research note on Wednesday, July 20th. Finally, Credit Suisse Group lifted their price objective on shares of UnitedHealth Group from $575.00 to $579.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Three equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $582.50.

UnitedHealth Group Stock Up 1.1 %

Shares of UNH traded up $5.90 during mid-day trading on Thursday, hitting $540.51. The company’s stock had a trading volume of 44,917 shares, compared to its average volume of 3,384,512. UnitedHealth Group Incorporated has a 52-week low of $383.12 and a 52-week high of $553.29. The company’s 50-day moving average is $500.41 and its 200-day moving average is $496.04. The company has a current ratio of 0.77, a quick ratio of 0.78 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $507.09 billion, a price-to-earnings ratio of 27.92, a PEG ratio of 1.64 and a beta of 0.77.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.24 by $0.33. The business had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business’s quarterly revenue was up 12.6% on a year-over-year basis. During the same quarter last year, the company posted $4.70 earnings per share. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 21.84 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th were paid a dividend of $1.65 per share. The ex-dividend date of this dividend was Thursday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.45. This represents a $6.60 dividend on an annualized basis and a yield of 1.22%. UnitedHealth Group’s payout ratio is 34.46%.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.